Jens C. Eickhoff
- Biophysics top 0.2%
- Oncology top 0.5%
- Cancer Immunotherapy and Biomarkers 28
- Cancer Treatment and Pharmacology 16
- Colorectal Cancer Treatments and Studies 15
- Immunology top 2%
- Immunotherapy and Immune Responses 26
-
- Prostate Cancer Treatment and Research 26
- Lung Cancer Treatments and Mutations 17
- Immunology and Allergy top 2%
-
- Obesity, Physical Activity, Diet 22
-
- Impact of Technology on Adolescents 20
- Co-authors
- Kevin W. EliceiriKristin M. RichingMegan A. MorenoAndreas FriedlMelissa C. SkalaAnnette Gendron‐FitzpatrickNirmala RamanujamPatricia J. Keely
- Cited by
- BiophysicsOncologyImmunology
- Journals
- Journal of Clinical Oncology (42 papers)Cancer Chemotherapy and Pharmacology (12 papers)The Journal of Pediatrics (12 papers)
- Partner nations
- United StatesGermanySwitzerland
In The Last Decade
Jens C. Eickhoff
362 papers receiving 11.0k citations
Hit Papers
Peers
Comparison fields: 5 of 195
- Biophysics 829
- Oncology 2.7k
- Immunology 1.4k
- Pulmonary and Respiratory Medicine 2.2k
- Immunology and Allergy 317
Countries citing papers authored by Jens C. Eickhoff
This map shows the geographic impact of Jens C. Eickhoff's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jens C. Eickhoff with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jens C. Eickhoff more than expected).
Fields of papers citing papers by Jens C. Eickhoff
This network shows the impact of papers produced by Jens C. Eickhoff. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jens C. Eickhoff. The network helps show where Jens C. Eickhoff may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Jens C. Eickhoff, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2025 | 0 | |
| 3 | 2025 | 0 | |
| 4 | 2024 | 2 | |
| 5 | 2024 | 1 | |
| 6 | 2024 | 1 | |
| 7 | 2023 | 0 | |
| 8 | 2023 | 3 | |
| 9 | 2023 | 6 | |
| 10 | 2021 | 1 | |
| 11 | 2021 | 2 | |
| 12 | 2020 | 47 | |
| 13 | 2020 | 4 | |
| 14 | 2019 | 26 | |
| 15 | 2018 | 6 | |
| 16 | 2014 | 48 | |
| 17 | 2014 | 33 | |
| 18 | 2013 | 85 | |
| 19 | 2011 | 72 | |
| 20 | 2011 | 39 |
About Jens C. Eickhoff
Jens C. Eickhoff is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Immunology, having authored 373 papers that have together received 11.3k indexed citations. Recurring topics across this work include Cancer Immunotherapy and Biomarkers (28 papers), Immunotherapy and Immune Responses (26 papers), Prostate Cancer Treatment and Research (26 papers), Obesity, Physical Activity, Diet (22 papers), Impact of Technology on Adolescents (20 papers), Lung Cancer Treatments and Mutations (17 papers), Cancer Treatment and Pharmacology (16 papers) and Colorectal Cancer Treatments and Studies (15 papers). The work is most often cited by research in Biophysics (829 citations), Oncology (2.7k citations) and Immunology (1.4k citations). Jens C. Eickhoff has collaborated with scholars based in United States, Germany and Switzerland. Frequent co-authors include Kevin W. Eliceiri, Kristin M. Riching, Megan A. Moreno, Andreas Friedl, Melissa C. Skala, Annette Gendron‐Fitzpatrick, Nirmala Ramanujam, Patricia J. Keely, Aaron L. Carrel and Lauren A. Jelenchick. Their work appears in journals such as Journal of Clinical Oncology, Cancer Chemotherapy and Pharmacology, The Journal of Pediatrics, Investigational New Drugs and Clinical Cancer Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.